Laboratory Total Operating Expenses vs Net Income Analysis

LH Stock

USD 251.54 5.32 2.16%

Laboratory financial indicator trend analysis is infinitely more than just investigating Laboratory recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Laboratory is a good investment. Please check the relationship between Laboratory Total Operating Expenses and its Net Income accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Total Operating Expenses vs Net Income

Total Operating Expenses vs Net Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Laboratory Total Operating Expenses account and Net Income. At this time, the significance of the direction appears to have weak relationship.

The correlation between Laboratory's Total Operating Expenses and Net Income is 0.31. Overlapping area represents the amount of variation of Total Operating Expenses that can explain the historical movement of Net Income in the same time period over historical financial statements of Laboratory of, assuming nothing else is changed. The correlation between historical values of Laboratory's Total Operating Expenses and Net Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Operating Expenses of Laboratory of are associated (or correlated) with its Net Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income has no effect on the direction of Total Operating Expenses i.e., Laboratory's Total Operating Expenses and Net Income go up and down completely randomly.

Correlation Coefficient

0.31

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Laboratory financial statement analysis. It represents the amount of money remaining after all of Laboratory of operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Most indicators from Laboratory's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Laboratory current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

As of now, Laboratory's Selling General Administrative is increasing as compared to previous years. The Laboratory's current Tax Provision is estimated to increase to about 379.6 M, while Issuance Of Capital Stock is projected to decrease to under 46.2 M.

	2022	2023	2024	2025 (projected)
Gross Profit	4.4B	3.4B	3.9B	2.0B
Total Revenue	14.9B	12.2B	14.0B	14.7B

Gross Profit Total Revenue

Laboratory fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Long Term Debt Total	Intangible Assets	Short Term Debt	Inventory	Property Plant And Equipment Gross	Common Stock	Common Stock Total Equity
Common Stock Shares Outstanding		0.58	0.47	0.52	0.47	0.41	0.65	0.49	0.49	0.32	0.62	0.15	0.32	0.49	0.75	0.12	0.11	0.66	0.42	0.74	0.65	0.29	0.32	0.22	0.94	0.89
Total Assets	0.58		0.51	0.73	0.98	0.95	0.93	0.95	0.92	0.58	0.99	0.55	0.58	0.95	0.9	0.57	0.38	0.98	0.95	0.94	0.86	0.15	0.85	0.78	0.56	0.31
Other Current Liab	0.47	0.51		0.69	0.53	0.43	0.42	0.57	0.43	0.12	0.51	0.26	0.12	0.42	0.42	0.62	-0.08	0.46	0.45	0.56	0.55	0.42	0.38	0.36	0.44	0.21
Total Current Liabilities	0.52	0.73	0.69		0.75	0.79	0.64	0.77	0.78	0.33	0.71	0.73	0.33	0.73	0.5	0.48	0.04	0.67	0.71	0.77	0.52	0.77	0.8	0.76	0.5	0.3
Total Stockholder Equity	0.47	0.98	0.53	0.75		0.96	0.85	0.99	0.92	0.6	0.96	0.64	0.6	0.96	0.81	0.63	0.28	0.92	0.98	0.87	0.8	0.18	0.9	0.85	0.48	0.18
Property Plant And Equipment Net	0.41	0.95	0.43	0.79	0.96		0.86	0.94	0.96	0.52	0.93	0.74	0.52	0.92	0.75	0.6	0.29	0.9	0.94	0.86	0.71	0.29	0.95	0.92	0.44	0.16
Net Debt	0.65	0.93	0.42	0.64	0.85	0.86		0.8	0.89	0.34	0.96	0.4	0.34	0.81	0.94	0.47	0.53	0.97	0.77	0.96	0.88	0.13	0.71	0.65	0.6	0.45
Retained Earnings	0.49	0.95	0.57	0.77	0.99	0.94	0.8		0.89	0.61	0.92	0.69	0.61	0.94	0.77	0.65	0.11	0.88	0.96	0.83	0.75	0.21	0.9	0.85	0.53	0.19
Accounts Payable	0.49	0.92	0.43	0.78	0.92	0.96	0.89	0.89		0.35	0.92	0.69	0.35	0.84	0.75	0.63	0.3	0.89	0.86	0.87	0.71	0.31	0.93	0.9	0.51	0.31
Cash	0.32	0.58	0.12	0.33	0.6	0.52	0.34	0.61	0.35		0.51	0.32	1.0	0.74	0.51	0.07	0.05	0.53	0.74	0.45	0.41	-0.04	0.51	0.41	0.37	0.1
Non Current Assets Total	0.62	0.99	0.51	0.71	0.96	0.93	0.96	0.92	0.92	0.51		0.51	0.51	0.92	0.93	0.55	0.42	0.99	0.9	0.96	0.89	0.14	0.82	0.74	0.59	0.36
Non Currrent Assets Other	0.15	0.55	0.26	0.73	0.64	0.74	0.4	0.69	0.69	0.32	0.51		0.32	0.62	0.25	0.41	-0.24	0.44	0.63	0.43	0.2	0.52	0.82	0.84	0.23	-0.04
Cash And Short Term Investments	0.32	0.58	0.12	0.33	0.6	0.52	0.34	0.61	0.35	1.0	0.51	0.32		0.74	0.51	0.07	0.05	0.53	0.74	0.45	0.41	-0.04	0.51	0.41	0.37	0.1
Net Receivables	0.49	0.95	0.42	0.73	0.96	0.92	0.81	0.94	0.84	0.74	0.92	0.62	0.74		0.8	0.42	0.29	0.9	0.97	0.85	0.77	0.19	0.86	0.77	0.48	0.19
Non Current Liabilities Total	0.75	0.9	0.42	0.5	0.81	0.75	0.94	0.77	0.75	0.51	0.93	0.25	0.51	0.8		0.38	0.49	0.96	0.76	0.93	0.91	-0.04	0.59	0.49	0.69	0.53
Other Current Assets	0.12	0.57	0.62	0.48	0.63	0.6	0.47	0.65	0.63	0.07	0.55	0.41	0.07	0.42	0.38		-0.01	0.49	0.58	0.44	0.43	0.08	0.63	0.66	0.21	-0.03
Other Stockholder Equity	0.11	0.38	-0.08	0.04	0.28	0.29	0.53	0.11	0.3	0.05	0.42	-0.24	0.05	0.29	0.49	-0.01		0.47	0.23	0.45	0.5	-0.19	0.12	0.1	-0.1	0.07
Total Liab	0.66	0.98	0.46	0.67	0.92	0.9	0.97	0.88	0.89	0.53	0.99	0.44	0.53	0.9	0.96	0.49	0.47		0.88	0.97	0.9	0.12	0.77	0.69	0.62	0.42
Total Current Assets	0.42	0.95	0.45	0.71	0.98	0.94	0.77	0.96	0.86	0.74	0.9	0.63	0.74	0.97	0.76	0.58	0.23	0.88		0.81	0.73	0.16	0.91	0.84	0.45	0.13
Short Long Term Debt Total	0.74	0.94	0.56	0.77	0.87	0.86	0.96	0.83	0.87	0.45	0.96	0.43	0.45	0.85	0.93	0.44	0.45	0.97	0.81		0.87	0.29	0.73	0.65	0.67	0.51
Intangible Assets	0.65	0.86	0.55	0.52	0.8	0.71	0.88	0.75	0.71	0.41	0.89	0.2	0.41	0.77	0.91	0.43	0.5	0.9	0.73	0.87		-0.02	0.55	0.46	0.57	0.34
Short Term Debt	0.29	0.15	0.42	0.77	0.18	0.29	0.13	0.21	0.31	-0.04	0.14	0.52	-0.04	0.19	-0.04	0.08	-0.19	0.12	0.16	0.29	-0.02		0.37	0.37	0.28	0.26
Inventory	0.32	0.85	0.38	0.8	0.9	0.95	0.71	0.9	0.93	0.51	0.82	0.82	0.51	0.86	0.59	0.63	0.12	0.77	0.91	0.73	0.55	0.37		0.96	0.4	0.12
Property Plant And Equipment Gross	0.22	0.78	0.36	0.76	0.85	0.92	0.65	0.85	0.9	0.41	0.74	0.84	0.41	0.77	0.49	0.66	0.1	0.69	0.84	0.65	0.46	0.37	0.96		0.29	0.03
Common Stock	0.94	0.56	0.44	0.5	0.48	0.44	0.6	0.53	0.51	0.37	0.59	0.23	0.37	0.48	0.69	0.21	-0.1	0.62	0.45	0.67	0.57	0.28	0.4	0.29		0.85
Common Stock Total Equity	0.89	0.31	0.21	0.3	0.18	0.16	0.45	0.19	0.31	0.1	0.36	-0.04	0.1	0.19	0.53	-0.03	0.07	0.42	0.13	0.51	0.34	0.26	0.12	0.03	0.85

Click cells to compare fundamentals

Laboratory Account Relationship Matchups

Laboratory fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Common Stock Shares Outstanding	98M	97.5M	91.6M	87.6M	100.7M	96.0M
Total Assets	20.1B	20.4B	20.2B	16.7B	19.2B	20.2B
Other Current Liab	784.2M	967M	1.6B	676.5M	778.0M	484.1M
Total Current Liabilities	2.6B	3.1B	2.8B	3.2B	3.7B	3.9B
Total Stockholder Equity	9.4B	10.3B	10.1B	7.9B	9.1B	9.5B
Property Plant And Equipment Net	2.7B	2.8B	3.0B	2.9B	3.3B	3.5B
Net Debt	5.4B	4.9B	5.9B	5.4B	6.2B	6.5B
Retained Earnings	9.4B	10.5B	10.6B	7.9B	9.1B	9.5B
Accounts Payable	638.9M	621.3M	852.2M	827.5M	951.6M	999.2M
Cash	1.3B	1.5B	430M	536.8M	617.3M	648.2M
Non Current Assets Total	14.9B	15.1B	15.5B	13.0B	14.9B	15.6B
Non Currrent Assets Other	410M	462.6M	432.7M	536.5M	617.0M	647.8M
Cash And Short Term Investments	1.3B	1.5B	430M	536.8M	617.3M	648.2M
Net Receivables	3.0B	3.0B	2.0B	2.1B	2.4B	2.5B
Liabilities And Stockholders Equity	20.1B	20.4B	20.2B	16.7B	19.2B	20.2B
Non Current Liabilities Total	7.6B	7.3B	7.0B	5.6B	6.5B	6.8B
Other Current Assets	364.8M	478.1M	2.4B	655.3M	753.6M	791.3M
Other Stockholder Equity	110.3M	(192M)	(493.2M)	38.4M	34.6M	32.8M
Total Liab	10.7B	10.1B	10.1B	8.8B	10.2B	10.7B
Total Current Assets	5.1B	5.3B	4.6B	3.8B	4.3B	4.5B
Short Long Term Debt Total	6.8B	6.3B	6.3B	6.0B	6.8B	7.2B
Intangible Assets	4.0B	3.7B	3.9B	3.3B	3.8B	2.0B
Short Term Debt	774.1M	396.5M	471.1M	1.2B	1.3B	1.4B
Inventory	423.2M	401.4M	470.6M	474.6M	545.8M	573.1M
Property Plant And Equipment Gross	2.7B	5.2B	5.7B	5.8B	6.7B	7.0B
Accumulated Other Comprehensive Income	(161.9M)	(192M)	(493.2M)	(59.3M)	(53.4M)	(56.0M)
Other Liab	1.3B	1.4B	1.2B	1.1B	1.2B	702.7M
Other Assets	356.5M	350.9M	484.2M	440.3M	506.3M	531.7M
Long Term Debt	5.4B	5.4B	5.0B	4.1B	4.7B	3.1B
Property Plant Equipment	2.7B	2.8B	2.8B	3.0B	3.4B	3.6B
Good Will	7.8B	8.0B	8.1B	6.1B	7.1B	4.4B
Current Deferred Revenue	506.5M	558.5M	582.1M	421.7M	485.0M	509.2M
Net Tangible Assets	(4.3B)	(2.4B)	(1.4B)	(2.0B)	(1.8B)	(1.9B)
Long Term Debt Total	5.9B	5.5B	5.5B	5.1B	5.9B	4.8B

Currently Active Assets on Macroaxis

F	Ford Motor
GM	General Motors
S	SentinelOne
GOOG	Alphabet Inc Class C
WD	Walker Dunlop

How To Invest In Laboratory

Details

Is Laboratory Stock a good investment?

Details

What is Laboratory's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.05)

Dividend Share

2.88

Earnings Share

5.27

Revenue Per Share

151.028

Quarterly Revenue Growth

0.074

The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Laboratory Total Operating Expenses vs Net Income Analysis

Total Operating Expenses vs Net Income

Total Operating Expenses vs Net Income Correlation Analysis

Correlation Coefficient

Total Operating Expenses

Net Income

Laboratory fundamental ratios Correlations

Laboratory Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Laboratory fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Non Current Assets Total	+ 0.99	Total Assets
Retained Earnings	+ 0.99	Total Stockholder Equity
Total Liab	+ 0.99	Non Current Assets Total
Total Stockholder Equity	+ 0.98	Total Assets
Total Liab	+ 0.98	Total Assets

Other Stockholder Equity	- 0.24	Non Currrent Assets Other
Short Term Debt	- 0.19	Other Stockholder Equity
Common Stock	- 0.1	Other Stockholder Equity
Other Stockholder Equity	- 0.08	Other Current Liab
Short Term Debt	- 0.04	Non Current Liabilities Total
Short Term Debt	- 0.04	Cash And Short Term Investments